0
SAFE Act
2/28/2025, 3:53 AM
Summary of Bill HR 830
The bill seeks to classify fentanyl analogues, which are substances that are chemically similar to fentanyl but have slight variations in their molecular structure, as Schedule I controlled substances. This classification would make it illegal to manufacture, distribute, or possess these substances without proper authorization.
The purpose of this legislation is to combat the spread of fentanyl analogues, which are often created in clandestine laboratories and sold on the black market. These substances are extremely potent and can be even more dangerous than fentanyl itself, leading to a higher risk of overdose and death. By classifying fentanyl analogues as Schedule I controlled substances, law enforcement agencies will have more tools to crack down on the production and distribution of these dangerous substances. This bill is part of a larger effort to address the opioid crisis in the United States and prevent further loss of life due to fentanyl-related overdoses. Overall, the Fentanyl Analogues Control Act is a crucial piece of legislation that aims to protect public health and safety by addressing the proliferation of fentanyl analogues in the illicit drug market.
Congressional Summary of HR 830
Save Americans from the Fentanyl Emergency Act or the SAFE Act
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on March 31, 2025.
It limits mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows federal courts to vacate or reduce sentences for convictions involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.
The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
Read the Full Bill
Current Status of Bill HR 830
Bipartisan Support of Bill HR 830
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
77Democrat Cosponsors
63Republican Cosponsors
14Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 830
Primary Policy Focus
Alternate Title(s) of Bill HR 830
Comments
Raiden Olsen
10 months ago
I can't believe this bill is even being considered. It's just another example of the government overstepping its boundaries and trying to control every aspect of our lives. It's ridiculous how they think they can just pass laws like this without considering the consequences. This is going to affect so many people in a negative way, and I for one am not happy about it. #governmentoverreach #notmygovernment Short comment: This bill is a disaster waiting to happen. #oppose
